Clinical Trial Update: Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating repurposed statins as microbiota-modulating therapy for ulcerative colitis has been terminated after Phase 2/3. The study is sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Statins

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: TERMINATED